GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Alcon Inc (NYSE:ALC) » Definitions » Price-to-Free-Cash-Flow

Alcon (ALC) Price-to-Free-Cash-Flow

: 437.09 (As of Today)
View and export this data going back to 2019. Start your Free Trial

As of today (2024-04-19), Alcon's share price is $79.55. Alcon's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.18. Hence, Alcon's Price-to-Free-Cash-Flow Ratio for today is 437.09.

The historical rank and industry rank for Alcon's Price-to-Free-Cash-Flow or its related term are showing as below:

ALC' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 61.42   Med: 136.23   Max: 776.92
Current: 431.95

During the past 8 years, Alcon's highest Price-to-Free-Cash-Flow Ratio was 776.92. The lowest was 61.42. And the median was 136.23.

ALC's Price-to-Free-Cash-Flow is ranked worse than
97.03% of 337 companies
in the Medical Devices & Instruments industry
Industry Median: 31.21 vs ALC: 431.95

Alcon's Free Cash Flow per Share for the three months ended in Dec. 2023 was $0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $0.18.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Alcon was 5.20% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 26.20% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 5.10% per year.

During the past 8 years, Alcon's highest 3-Year average Free Cash Flow per Share Growth Rate was 26.20% per year. The lowest was -31.70% per year. And the median was -29.20% per year.


Alcon Price-to-Free-Cash-Flow Historical Data

The historical data trend for Alcon's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alcon Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Premium Member Only Premium Member Only Premium Member Only 111.61 126.54 262.14 71.07 70.20

Alcon Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 71.07 61.91 146.15 419.76 70.20

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Alcon's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alcon Price-to-Free-Cash-Flow Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Alcon's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Alcon's Price-to-Free-Cash-Flow falls into.



Alcon Price-to-Free-Cash-Flow Calculation

Alcon's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=79.55/0.182
=437.09

Alcon's Share Price of today is $79.55.
Alcon's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.18.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Alcon  (NYSE:ALC) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Alcon Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Alcon's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Alcon (ALC) Business Description

Traded in Other Exchanges
Address
Chemin de Blandonnet 8, Royce Bedward, Vernier, Geneva, CHE, 1214
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.